Himali Weerahandi1, Nathan Goldstein2, Laura P Gelfman2, Ulrich Jorde3, James N Kirkpatrick4, Edith Meyerson2, Judith Marble5, Yoshifumi Naka6, Sean Pinney7, Mark S Slaughter8, Emilia Bagiella9, Deborah D Ascheim10. 1. Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: Himali.weerahandi@nyumc.org. 2. Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 3. Division of Cardiology, Montefiore Medical Center, Bronx, New York, USA. 4. Department of Medicine, University of Washington Medicine, Seattle, Washington, USA. 5. Department of Cardiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 6. Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, New York, USA. 7. Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 8. Thoracic and Cardiovascular Surgery Division, Department of Surgery, Jewish Hospital Louisville, Louisville, Kentucky, USA. 9. Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 10. Cedars-Sinai Medical Center, Los Angeles, California, USA.
Abstract
CONTEXT: Ventricular assist devices (VADs) improve quality of life in advanced heart failure patients, but there are little data exploring psychological symptoms in this population. OBJECTIVE: This study examined the prevalence of psychiatric symptoms and disease over time in VAD patients. METHODS: This prospective multicenter cohort study enrolled patients immediately before or after VAD implant and followed them up to 48 weeks. Depression and anxiety were assessed with Patient-Reported Outcomes Measurement Information System Short Form 8a questionnaires. The panic disorder, acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) modules of the Structured Clinical Interview for the DSM were used. RESULTS: Eighty-seven patients were enrolled. After implant, depression and anxiety scores decreased significantly over time (P = 0.03 and P < 0.001, respectively). Two patients met criteria for panic disorder early after implantation, but symptoms resolved over time. None met criteria for ASD or PTSD. CONCLUSIONS: Our study suggests VADs do not cause serious psychological harms and may have a positive impact on depression and anxiety. Furthermore, VADs did not induce PTSD, panic disorder, or ASD in this cohort.
CONTEXT: Ventricular assist devices (VADs) improve quality of life in advanced heart failurepatients, but there are little data exploring psychological symptoms in this population. OBJECTIVE: This study examined the prevalence of psychiatric symptoms and disease over time in VAD patients. METHODS: This prospective multicenter cohort study enrolled patients immediately before or after VAD implant and followed them up to 48 weeks. Depression and anxiety were assessed with Patient-Reported Outcomes Measurement Information System Short Form 8a questionnaires. The panic disorder, acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) modules of the Structured Clinical Interview for the DSM were used. RESULTS: Eighty-seven patients were enrolled. After implant, depression and anxiety scores decreased significantly over time (P = 0.03 and P < 0.001, respectively). Two patients met criteria for panic disorder early after implantation, but symptoms resolved over time. None met criteria for ASD or PTSD. CONCLUSIONS: Our study suggests VADs do not cause serious psychological harms and may have a positive impact on depression and anxiety. Furthermore, VADs did not induce PTSD, panic disorder, or ASD in this cohort.
Authors: M M Weissman; R C Bland; G J Canino; C Faravelli; S Greenwald; H G Hwu; P R Joyce; E G Karam; C K Lee; J Lellouch; J P Lépine; S C Newman; M Rubio-Stipec; J E Wells; P J Wickramaratne; H Wittchen; E K Yeh Journal: JAMA Date: 1996 Jul 24-31 Impact factor: 56.272
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Edward P Havranek; John A Spertus; Frederick A Masoudi; Philip G Jones; John S Rumsfeld Journal: J Am Coll Cardiol Date: 2004-12-21 Impact factor: 24.094
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2010-01 Impact factor: 10.247